An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
Clinical trial NCT04620811 · COMPLETED
Trial details
- NCT number
- NCT04620811
- Sponsor
- Allakos Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-03
- Primary completion
- 2023-05-15
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.